Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information

Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized clinical trials accounting for classical risk factors, such as hypertension, diabetes, and serum lipids. However, besides such classical risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Hayato, Usui, Soichiro, Sakata, Kenji, Takamura, Masayuki, Kawashiri, Masa-aki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147010/
https://www.ncbi.nlm.nih.gov/pubmed/33229815
http://dx.doi.org/10.5551/jat.60087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147010/
https://www.ncbi.nlm.nih.gov/pubmed/33229815
http://dx.doi.org/10.5551/jat.60087

Ejemplares similares